FindTrial
Sign In

To compare the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as an augmentation strategy vs conventional treatment of depression

A study to compare the efficacy of high frequency repetitive Transcranial Magnetic Stimulation (rTMS) as an augmentation strategy vs conventional treatment of non psychotic, unipolar depression in a tertiary care hospital in Western Maharashtra - rTMSAFMC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011890
Enrollment
100
Registered
2018-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Depressive Episode

Interventions

Intervention1: rTMS along with anti-depressant treatment: ATES magnetic stimulator, RTS 9000, high frequency stimulation more than 5Hz, over Left PFC.They are also given anti-depressant treatment Cont

Sponsors

Director General Armed Forces Medical Services
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from unipolar depression (non psychotic, Single episode or recurrent depression) - diagnosed as per ICD-10 criteria by a qualified psychiatrist. 2. Pass the TMS adult safety screening (TASS) test

Exclusion criteria

Exclusion criteria: 1. Suicidal patient 2. Psychotic depression

Design outcomes

Secondary

MeasureTime frame
Partial Response as measured by reduction in HAMD score between 25% and 50 %Timepoint: 0 and 4 weeks—

Primary

MeasureTime frame
Response as measured by reduction in HAM-D score by 50 %Timepoint: 0 and 4 weeks—

Countries

India

Contacts

Public ContactDr Rajiv K Saini

Armed Forces Medical College, Pune

rks197019@gmail.com9168756403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026